Costs and cost effectiveness of health checks conducted by nurses in primary care : the Oxcheck study.
To measure the costs and cost effectiveness of the Oxcheck cardiovascular risk factor screening and intervention programme.
Design-Cost effectiveness analysis of a randomised controlled trial using clinical and economc data taken from the trial.
Setting-Five general practices in Luton and Dunstable, England.
Subjects-2205 patients who attended a health check in 1989-90 and were scheduled for reexamination in 1992-3 (intervention group) ; 1916 patients who attended their initial health check in 1992-3 (control group).
Participants were men and women aged 35-64years.
Intervention-Health check conducted by nurse, with health education and follow up according to degree of risk.
Main outcome measures-Cost of health check programme ; cost per 1% reduction in coronary risk.
Health check and follow up cost £29.27 per patient.
Estimated programme cost per 1% reduction in coronary risk per participant was between £1.46 and £2.25 ; it was nearly twice as much for men as women.
Conclusions-The cost to the practice of implementing Oxcheck-style health checks in an average sized practice of 7500 patients would be £47 000, a proportion of which could be paid for through staff pay reimbursements and Band Three health promotion target payments.
This study highlights the considerable difficulties faced when calculating the costs and benefits of a health promotion programme.
Economic evaluations should be integrated into the protocols of randomised controll...
Mots-clés Pascal : Soin santé primaire, Bilan santé, Risque, Cardiopathie, Vaisseau sanguin pathologie, Surveillance, Politique sanitaire, Education sanitaire, Infirmier, Analyse coût efficacité, Homme, Grande Bretagne, Royaume Uni, Europe, Appareil circulatoire pathologie, Etude Oxcheck
Mots-clés Pascal anglais : Primary health care, Medical check up, Risk, Heart disease, Vascular disease, Surveillance, Health policy, Health education, Nurse, Cost efficiency analysis, Human, Great Britain, United Kingdom, Europe, Cardiovascular disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0279783
Code Inist : 002B30A03B. Création : 199608.